Bacterial and Fungal Superinfections in COVID-19 Patients Hospitalized in an Intensive Care Unit from Timișoara, Romania

References

• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5)30183-5
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMOA2001017/SUPPL_FILE/NEJMOA2001017_DISCLOSURES.PDF
   PubMed Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–943. doi:10.1001/JAMAINTERNMED.2020.0994
   PubMed Web of Science ®Google Scholar
• Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574–1581. doi:10.1001/JAMA.2020.5394
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of Coronavirus Disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–793. doi:10.1001/JAMA.2020.12839
   PubMed Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X
   PubMed Web of Science ®Google Scholar
• Docea AO, Tsatsakis A, Albulescu D, et al. A new threat from an old enemy: re-emergence of coronavirus. Int J Mol Med. 2020;45(6):1631–1643. doi:10.3892/IJMM.2020.4555/HTML
   Web of Science ®Google Scholar
• Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459–2468. doi:10.1093/CID/CIAA530
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Martín-Loeches I, Sanchez-Corral A, Diaz E, et al. Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus. Chest. 2011;139(3):555–562. doi:10.1378/chest.10-1396
   PubMed Web of Science ®Google Scholar
• Antimicrobial resistance surveillance in Europe 2022-2020 data. Available from: https://www.ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2022-2020-data. Accessed November 23, 2022.
   Google Scholar
• Antimicrobial resistance in the EU/EEA (EARS-Net) - annual epidemiological report for 2019. Available from: https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2019. Accessed November 23, 2022.
   Google Scholar
• Coppola S, Ciabattoni A, Pozzi T, Castagna V, Bassi GL, Chiumello D. Hazardous mismatch between pulmonary pathogens and antibiotic treatments in COVID-19 patients. Br J Anaesth. 2020;125(4):e380–e382. doi:10.1016/j.bja.2020.07.019
   Web of Science ®Google Scholar
• COVID-19 treatment guidelines. Available from: https://www.covid19treatmentguidelines.nih.gov/. Accessed November 23, 2022.
   Google Scholar
• Decizia de punere în aplicare (UE) 2018/945 a Comisiei din 22 iunie 2018 privind bolile transmisibile și problemele de sănătate speciale conexe care trebuie să facă obiectul supravegherii epidemiologice, precum și definițiile de caz relevante (Text cu relevanță pentru SEE.) - Publications Office of the EU. Available from: https://op.europa.eu/ro/publication-detail/-/publication/57ed0506-80e4-11e8-ac6a-01aa75ed71a1. Accessed November 23, 2022.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020;26(10):1395–1399. doi:10.1016/j.cmi.2020.06.025
   PubMed Web of Science ®Google Scholar
• Buehler PK, Zinkernagel AS, Hofmaenner DA, et al. Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients. Cell Rep Med. 2021;2(4):100229. doi:10.1016/j.xcrm.2021.100229
   Google Scholar
• Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622–1629. doi:10.1016/j.cmi.2020.07.016
   PubMed Web of Science ®Google Scholar
• Moreno-Torres V, de Mendoza C, de la Fuente S, et al. Bacterial infections in patients hospitalized with COVID-19. Intern Emerg Med. 2022;17(2):431–438. doi:10.1007/S11739-021-02824-7/FIGURES/1
   Web of Science ®Google Scholar
• Cataño-Correa JC, Cardona-Arias JA, Mancilla JPP, García MT. Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellín-Colombia, 2020 PLoS One. 2021;16(7):e0254671. doi:10.1371/JOURNAL.PONE.0254671
   PubMed Web of Science ®Google Scholar
• Signorini L, Moioli G, Calza S, et al. Epidemiological and clinical characterization of superinfections in critically ill coronavirus disease 2019 patients. Crit Care Explor. 2021;3(6):e0430. doi:10.1097/CCE.0000000000000430
   Google Scholar
• Marinescu AR, Laza R, Musta VF, et al. Clostridium difficile and COVID-19: general data, ribotype, clinical form, treatment-our experience from the largest infectious diseases hospital in Western Romania. Medicina 2021, 57(10):1099. doi:10.3390/MEDICINA57101099
   Web of Science ®Google Scholar
• Nasir N, Rehman F, Omair SF. Risk factors for bacterial infections in patients with moderate to severe COVID-19: a case-control study. J Med Virol. 2021;93(7):4564–4569. doi:10.1002/JMV.27000
   PubMed Web of Science ®Google Scholar
• Protocol-tratament-covid19-ms. Available from: https://www.cnscbt.ro/index.php/legislatie_cov/1617-protocolul-de-tratament-covid-19/file. Accessed September 17, 2022.
   Google Scholar
• Rus M, Licker M, Musuroi C, et al. Distribution of NDM1 carbapenemase-producing proteeae strains on high-risk hospital wards. Infect Drug Resist. 2020;13:4751–4761. doi:10.2147/IDR.S280977
   Web of Science ®Google Scholar
• Muntean D, Licker M, Horhat F, et al. Extensively drug-resistant Acinetobacter baumannii and proteeae association in a Romanian intensive care unit: risk factors for acquisition. Infect Drug Resist. 2018;11:2187–2197. doi:10.2147/IDR.S171288
   PubMed Web of Science ®Google Scholar
• Ramadan HKA, Mahmoud MA, Zakaria M, et al. Predictors of severity and co-infection resistance profile in COVID-19 patients: first report from upper Egypt. Infect Drug Resist. 2020;13:3409–3422. doi:10.2147/IDR.S272605
   Web of Science ®Google Scholar
• Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266–275. doi:10.1016/j.jinf.2020.05.046
   PubMed Web of Science ®Google Scholar
• Guo M, Gao M, Gao J, et al. Identifying risk factors for secondary infection post-SARS-CoV-2 infection in patients with severe and critical COVID-19. Front Immunol. 2021;12:3601. doi:10.3389/FIMMU.2021.715023/BIBTEX
   Web of Science ®Google Scholar
• Laza R, Lazureanu VE, Musta VF, et al. COVID-19 independent risk factors for unfavorable disease progression: a cross-sectional study from Romania. Int J Gen Med. 2022;15:2025–2036. doi:10.2147/IJGM.S350920
   Web of Science ®Google Scholar
• Llitjos JF, Bredin S, Lascarrou JB, et al. Increased susceptibility to intensive care unit-acquired pneumonia in severe COVID-19 patients: a multicentre retrospective cohort study. Ann Intensive Care. 2021;11(1):1–8. doi:10.1186/S13613-021-00812-W/TABLES/3
   Web of Science ®Google Scholar
• Nebreda-Mayoral T, Miguel-Gómez MA, March-Rosselló GA, et al. Bacterial/fungal infection in hospitalized patients with COVID-19 in a tertiary hospital in the community of Castilla y León, Spain. Enferm Infecc Microbiol Clin 2022;40(4):158–165. doi:10.1016/J.EIMCE.2022.02.002
   Web of Science ®Google Scholar
• Wang L, He W, Yu X, et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020;80(6):639–645. doi:10.1016/J.JINF.2020.03.019
   PubMed Web of Science ®Google Scholar
• Ferrando C, Mellado-Artigas R, Gea A, et al. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: a prospective, cohort, multicentre study. Rev Esp Anestesiol Reanim 2020;67(8):425–437. doi:10.1016/J.REDARE.2020.07.001
   Web of Science ®Google Scholar
• Farrell JM, Zhao CY, Tarquinio KM, Brown SP. Causes and consequences of COVID-19-associated bacterial infections. Front Microbiol. 2021;12:1911. doi:10.3389/FMICB.2021.682571/BIBTEX
   Web of Science ®Google Scholar
• APACHE II: a severity of disease classification system - PubMed. Available from: https://pubmed.ncbi.nlm.nih.gov/3928249/. Accessed November 23, 2022.
   Google Scholar
• Carmeli Y. Strategies for managing today’s infections. Clin Microbiol Infect. 2008;14(SUPPL. 3):22–31. doi:10.1111/j.1469-0691.2008.01957.x
   Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8)90171-8
   PubMedGoogle Scholar